Kasuga Hisao, Hosogane Naobumi, Matsuoka Kunio, Mori Ikuo, Sakura Yasufumi, Shimakawa Kozo, Shinki Toshimasa, Suda Tatsuo, Taketomi Shigehisa
Pharmaceutical Research Division, Takeda Chemical Industries, 17-85 Jusohonmachi, 2-chome, Yodokawa-ku, 532-8686, Osaka, Japan.
Biochem Biophys Res Commun. 2002 Oct 11;297(5):1332-8. doi: 10.1016/s0006-291x(02)02254-4.
Vitamin D-24-hydroxylase (CYP24) is one of the enzymes responsible for vitamin D metabolism. CYP24 catalyzes the conversion of 25-hydroxyvitamin D(3) [25(OH)D(3)] to 24,25-dihydroxyvitamin D(3) [24,25(OH)(2)D(3)] in the kidney. CYP24 is also involved in the breakdown of 1alpha,25-dihydroxyvitamin D(3) [1alpha,25(OH)(2)D(3)], the active form of vitamin D(3). In this study, we generated transgenic (Tg) rats constitutively expressing CYP24 gene to investigate the biological role of CYP24 in vivo. Surprisingly, the Tg rats showed a significantly low level of plasma 24,25(OH)(2)D(3). Furthermore, the Tg rats developed albuminuria and hyperlipidemia shortly after weaning. The plasma lipid profile revealed that all lipoprotein fractions were elevated in the Tg rats. Also, the Tg rats showed atherosclerotic lesions in the aorta, which greatly progressed with high-fat and high-cholesterol feeding. These unexpected results suggest that CYP24 is involved in functions other than the regulation of vitamin D metabolism.
维生素D-24-羟化酶(CYP24)是负责维生素D代谢的酶之一。CYP24在肾脏中催化25-羟基维生素D(3) [25(OH)D(3)]转化为24,25-二羟基维生素D(3) [24,25(OH)(2)D(3)]。CYP24还参与维生素D(3)的活性形式1α,25-二羟基维生素D(3) [1α,25(OH)(2)D(3)]的分解。在本研究中,我们构建了组成型表达CYP24基因的转基因(Tg)大鼠,以研究CYP24在体内的生物学作用。令人惊讶的是,Tg大鼠血浆中24,25(OH)(2)D(3)水平显著降低。此外,Tg大鼠在断奶后不久就出现了蛋白尿和高脂血症。血浆脂质谱显示,Tg大鼠所有脂蛋白组分均升高。而且,Tg大鼠主动脉出现动脉粥样硬化病变,在高脂高胆固醇喂养后病变显著进展。这些意外结果表明,CYP24除了参与维生素D代谢调节外,还参与其他功能。